US drug approvals
23 approvals with a product on the US market
- Bisoprolol Fumarate And Hydrochlorothiazide ANDA219489 · approved 24 Mar 2026
- Amitriptyline Hydrochloride ANDA218389 · approved 23 Jun 2025
- Bisoprolol Fumarate ANDA219044 · approved 16 Apr 2025
- Enalapril Maleate ANDA218531 · approved 19 Sep 2024
- Doxepin Hydrochloride ANDA217975 · approved 21 Aug 2023
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.